Cubans develop synthetic vaccines

Cuban researchers have produced the first synthetic vaccine against pneumonia and meningitis, press reports said on Saturday.

    Discovery may lead to the future of disease prevention

    Vicente Verez, head of the University of Havana's Antigen Research Center, told the Cuban press agency AIN the vaccine would be presented to a biotechnology congress in Havana from 23-28 November.

    He said the vaccine was designed to be administered to infants in three doses - at two, four and six months - with a booster at 18 months.

    Clinical studies done in Camaguay in central Cuba showed that more than 99% of babies vaccinated developed antibodies against the pneumonia and meningitis viruses as well as other diseases, he said.

    Synthetically produced vaccines offer many advantages over conventional vaccines, including enhanced purity and effectiveness. They also have a longer shelf life and can be mass produced, potentially at a lower cost.

    SOURCE: AFP


    YOU MIGHT ALSO LIKE

    'It takes a village to kill a child': Uganda's hidden children

    'It takes a village to kill a child': Uganda's hidden children

    Faced with stigma and abuse, many children with disabilities are hidden indoors, with few options for specialised care.

    Medieval Arabic cookbooks: Reviving the taste of history

    Medieval Arabic cookbooks: Reviving the taste of history

    A growing number of cookbooks have been translated into English, helping bring old foods to new palates.

    India-China border row explained in seven maps

    India-China border row explained in seven maps

    Seven maps to help you understand the situation on the ground and what's at stake for nearly three billion people.